Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

Pediatric Infectious Disease Journal

Volumn 23, Issue 4, 2004, Pages 300-306

  Kanra, Güler ^a   Marchisio, Paola ^b   Feiterna Sperling, Cornelia ^c   Gaedicke, Gerhard ^c   Lazar, Hedvika ^d   Durrer, Peter ^d   Kürsteiner, Oliver ^d   Herzog, Christian ^d   Kara, Ates ^a   Principi, Nicola ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF MILAN   (Italy)

^c HUMBOLDT UNIVERSITY   (Germany)

^d Berna Biotech AG   (Switzerland)

Author keywords

Children; Infants; Influenza; Vaccine; Virosome

Indexed keywords

INFLUENZA VACCINE; VIROSOME;

ADJUVANT THERAPY; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; HEMAGGLUTINATION INHIBITION TEST; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; INFLUENZA; IRRITABILITY; MAJOR CLINICAL STUDY; MALAISE; MALE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SHIVERING; SIDE EFFECT; SKIN INDURATION; STRAIN DIFFERENCE; VACCINATION; VIRUS PARTICLE;

CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY; IMMUNIZATION SCHEDULE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRAMUSCULAR; MALE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; VACCINES, INACTIVATED; VACCINES, VIROSOME;

EID: 11144353907     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200404000-00005     Document Type: Article

References (28)

1. Marshall BC, Henshaw C, Evans DA, Bleyl K, Alder S, Liou TG. Influenza vaccination coverage level at a cystic fibrosis center. Pediatrics 2002;109:e80.
2. Kingston BJ, Wright CV Jr. Influenza in the nursing home. Am Fam Physician 2002;65:72, 75-8.
3. Redding G, Walker RE, Hessel C, et al. Safety and tolerability of cold-adapted influenza vaccine in children and adolescents with asthma. J Pediatr Infect Dis 2002;21:44-8.
4. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
5. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001;358:1410-6.
6. Longini IM, Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza. Am J Epidemiol 1982;115:736-51.
7. Fox JP, Hall CE, Cooney MK, Fox HM. Influenza virus infections in Seattle families, 1975-1979: Part I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol 1982;116:212-27.
8. Wright P. Influenza in the family. N Engl J Med 2000;343:1331-2.
9. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating school children against influenza. N Engl J Med 2001;344:889-96.
10. Esposito S, Marchisio P, Gasparini R, et al. Effect of influenza vaccination of healthy children in reducing influenza-related morbidity among household contacts. Poster presentation at European Society for Paediatric Infectious Diseases, 2003.
11. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2002;51:1-31.
12. McIntosh K, Lieu L. Is it time to give influenza vaccine to healthy infants? N Engl J Med 2000;342:275-80.
13. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
14. Moreno MV, Cabrerizo MR, Rincon MJ, Gomez CG, Gomez AJ. Adverse effects associated with influenza vaccine in pediatrics. Rev Esp Salud Publica 1998;72:319-29.
15. Couch RB, Keitel WA, Cate TR. Improvement of inactivated influenza vaccines. J Infect Dis 1997;176:38-44.
16. Moser C, Metcalfe IC, Viret JF. Virosomal adjuvanted antigen delivery systems. Expert Rev Vaccines 2003;2:189-96.
17. Conne P, Gauthey L, Vernet P, et al. Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients. Vaccine 1997;15:1675-9.
18. Cryz SJ, Que JU, Glück R. A virosome vaccine delivery system does not stimulate an antiphospholipid antibody response in humans. Vaccine 1996;14:1381-3.
19. Loutan L, Bovier P, Althaus B, Glück R. Inactivated virosome hepatitis A vaccine. Lancet 1994;343:322-4.
20. Lea AP, Balfour JA. Virosomal hepatitis A vaccine (strain RG-SB): a preliminary review of its immunogenicity, protective efficacy and tolerability in at-risk populations. BioDrugs 1997;7:232-48.
21. Glück R, Mischler R, Finkel B, Que JU, Scarpa B, Cryz SJ Jr. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994;344:160-163.
22. Herzog C, Metcalfe IC, Schaad UB. Virosome influenza vaccine in children. Vaccine 2002;20:B24-8.
23. Mischler R, Metcalfe IC. Inflexal V, a trivalent virosome subunit influenza vaccine: production. Vaccine 2002;20(Suppl 5):B17-23.
24. The European Agency for the Evaluation of Medicinal Products (EMEA); Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96), London, March 12, 1997.
25. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis 1987;136:550-5.
26. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000;284:1677-82.
27. Schaad UB, Buhlmann U, Burger R, et al. Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis. Antimicrob Agents Chemother 2000;44:1163-7.
28. Zuccotti GV, Cucchi C, Sala D, Giovannini M. Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children. Acta Paediatr 2002;91:486-7.